Previously, it was reported that T2DM and dysbiosis of gut microbiota led to impaired intestinal permeability (51), increased LPS levels and caused endotoxemia and metabolic disorders (52), which eventually affected the expression of colon tight junction proteins (ZO-1, occludin, and claudin-1) (51). This evidence concerns the gene CLDN1 and metabolic disease.